QUINOLINE DERIVATIVES AS ANTIBACTERIAL AGENTS

Use of a compound for the manufacture of a medicament for the treatment of a bacterial infection provided that the bacterial infection is other than a Mycobacterial infection, said compound being a compound of formula (Ia) or (Ib) a pharmaceutically acceptable acid or base addition salt thereof, a s...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: LIEVEN MEERPOEL, ANIL KOUL, JEROME E.G. GUILLEMONT, DAVID F.A. LANCOIS, KOENRAAD J.L.M. ANDRIES, ISMET DORANGE, LEO J.J. BACKX, MAGALI M.S. MOTTE
Format: Patent
Sprache:eng ; por
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator LIEVEN MEERPOEL
ANIL KOUL
JEROME E.G. GUILLEMONT
DAVID F.A. LANCOIS
KOENRAAD J.L.M. ANDRIES
ISMET DORANGE
LEO J.J. BACKX
MAGALI M.S. MOTTE
description Use of a compound for the manufacture of a medicament for the treatment of a bacterial infection provided that the bacterial infection is other than a Mycobacterial infection, said compound being a compound of formula (Ia) or (Ib) a pharmaceutically acceptable acid or base addition salt thereof, a stereochemically isomeric form thereof, a tautomeric form thereof or a N-oxide form thereof, wherein R1 is hydrogen, halo, haloalkyl, cyano, hydroxy, Ar, Het, alkyl, alkyloxy, alkylthio, alkyloxyalkyl, alkylthioalkyl, Ar-alkyl or di(Ar)alkyl; p is 1, 2, 3 or 4; R2 is hydrogen, hydroxy, mercapto, alkyloxy, alkyloxyalkyloxy, alkylthio, mono or di(alkyl)amino or a radical of formula; R3 is alkyl, Ar, Ar-alkyl, Het or Het-alkyl; q is 1, 2 or 3; R4 and R5 are hydrogen, alkyl or benzyl; or R4 and R5 together and including the N to which they are attached may form a ring; R6 is hydrogen, halo, haloalkyl, hydroxy, Ar, alkyl, alkyloxy, alkylthio, alkyloxyalkyl, alkythioalkyl, Ar-alkyl or di(Ar)alkyl; or two vicinal R6 radicals may be taken together to form a bivalent radical of formula -CH CH-CH CH-; r is 1, 2, 3, 4 or 5; R7 is hydrogen, alkyl, Ar or Het; R8 is hydrogen or alkyl; R9 is oxo; or R8 and R9 together form the radical -CH CH-N .
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_PT1898914EE</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>PT1898914EE</sourcerecordid><originalsourceid>FETCH-epo_espacenet_PT1898914EE3</originalsourceid><addsrcrecordid>eNrjZNANDPX08_fx9HNVcHEN8gxzDPEMcw1WcAQivxBPJ0fnEKCoo4-Co7urX0gwDwNrWmJOcSovlOZmUHBzDXH20E0tyI9PLS5ITE7NSy2JDwgxtLC0sDQ0cXU1JkIJAJJwJZ0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>QUINOLINE DERIVATIVES AS ANTIBACTERIAL AGENTS</title><source>esp@cenet</source><creator>LIEVEN MEERPOEL ; ANIL KOUL ; JEROME E.G. GUILLEMONT ; DAVID F.A. LANCOIS ; KOENRAAD J.L.M. ANDRIES ; ISMET DORANGE ; LEO J.J. BACKX ; MAGALI M.S. MOTTE</creator><creatorcontrib>LIEVEN MEERPOEL ; ANIL KOUL ; JEROME E.G. GUILLEMONT ; DAVID F.A. LANCOIS ; KOENRAAD J.L.M. ANDRIES ; ISMET DORANGE ; LEO J.J. BACKX ; MAGALI M.S. MOTTE</creatorcontrib><description>Use of a compound for the manufacture of a medicament for the treatment of a bacterial infection provided that the bacterial infection is other than a Mycobacterial infection, said compound being a compound of formula (Ia) or (Ib) a pharmaceutically acceptable acid or base addition salt thereof, a stereochemically isomeric form thereof, a tautomeric form thereof or a N-oxide form thereof, wherein R1 is hydrogen, halo, haloalkyl, cyano, hydroxy, Ar, Het, alkyl, alkyloxy, alkylthio, alkyloxyalkyl, alkylthioalkyl, Ar-alkyl or di(Ar)alkyl; p is 1, 2, 3 or 4; R2 is hydrogen, hydroxy, mercapto, alkyloxy, alkyloxyalkyloxy, alkylthio, mono or di(alkyl)amino or a radical of formula; R3 is alkyl, Ar, Ar-alkyl, Het or Het-alkyl; q is 1, 2 or 3; R4 and R5 are hydrogen, alkyl or benzyl; or R4 and R5 together and including the N to which they are attached may form a ring; R6 is hydrogen, halo, haloalkyl, hydroxy, Ar, alkyl, alkyloxy, alkylthio, alkyloxyalkyl, alkythioalkyl, Ar-alkyl or di(Ar)alkyl; or two vicinal R6 radicals may be taken together to form a bivalent radical of formula -CH CH-CH CH-; r is 1, 2, 3, 4 or 5; R7 is hydrogen, alkyl, Ar or Het; R8 is hydrogen or alkyl; R9 is oxo; or R8 and R9 together form the radical -CH CH-N .</description><language>eng ; por</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2012</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20121120&amp;DB=EPODOC&amp;CC=PT&amp;NR=1898914E$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25544,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20121120&amp;DB=EPODOC&amp;CC=PT&amp;NR=1898914E$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>LIEVEN MEERPOEL</creatorcontrib><creatorcontrib>ANIL KOUL</creatorcontrib><creatorcontrib>JEROME E.G. GUILLEMONT</creatorcontrib><creatorcontrib>DAVID F.A. LANCOIS</creatorcontrib><creatorcontrib>KOENRAAD J.L.M. ANDRIES</creatorcontrib><creatorcontrib>ISMET DORANGE</creatorcontrib><creatorcontrib>LEO J.J. BACKX</creatorcontrib><creatorcontrib>MAGALI M.S. MOTTE</creatorcontrib><title>QUINOLINE DERIVATIVES AS ANTIBACTERIAL AGENTS</title><description>Use of a compound for the manufacture of a medicament for the treatment of a bacterial infection provided that the bacterial infection is other than a Mycobacterial infection, said compound being a compound of formula (Ia) or (Ib) a pharmaceutically acceptable acid or base addition salt thereof, a stereochemically isomeric form thereof, a tautomeric form thereof or a N-oxide form thereof, wherein R1 is hydrogen, halo, haloalkyl, cyano, hydroxy, Ar, Het, alkyl, alkyloxy, alkylthio, alkyloxyalkyl, alkylthioalkyl, Ar-alkyl or di(Ar)alkyl; p is 1, 2, 3 or 4; R2 is hydrogen, hydroxy, mercapto, alkyloxy, alkyloxyalkyloxy, alkylthio, mono or di(alkyl)amino or a radical of formula; R3 is alkyl, Ar, Ar-alkyl, Het or Het-alkyl; q is 1, 2 or 3; R4 and R5 are hydrogen, alkyl or benzyl; or R4 and R5 together and including the N to which they are attached may form a ring; R6 is hydrogen, halo, haloalkyl, hydroxy, Ar, alkyl, alkyloxy, alkylthio, alkyloxyalkyl, alkythioalkyl, Ar-alkyl or di(Ar)alkyl; or two vicinal R6 radicals may be taken together to form a bivalent radical of formula -CH CH-CH CH-; r is 1, 2, 3, 4 or 5; R7 is hydrogen, alkyl, Ar or Het; R8 is hydrogen or alkyl; R9 is oxo; or R8 and R9 together form the radical -CH CH-N .</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2012</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNANDPX08_fx9HNVcHEN8gxzDPEMcw1WcAQivxBPJ0fnEKCoo4-Co7urX0gwDwNrWmJOcSovlOZmUHBzDXH20E0tyI9PLS5ITE7NSy2JDwgxtLC0sDQ0cXU1JkIJAJJwJZ0</recordid><startdate>20121120</startdate><enddate>20121120</enddate><creator>LIEVEN MEERPOEL</creator><creator>ANIL KOUL</creator><creator>JEROME E.G. GUILLEMONT</creator><creator>DAVID F.A. LANCOIS</creator><creator>KOENRAAD J.L.M. ANDRIES</creator><creator>ISMET DORANGE</creator><creator>LEO J.J. BACKX</creator><creator>MAGALI M.S. MOTTE</creator><scope>EVB</scope></search><sort><creationdate>20121120</creationdate><title>QUINOLINE DERIVATIVES AS ANTIBACTERIAL AGENTS</title><author>LIEVEN MEERPOEL ; ANIL KOUL ; JEROME E.G. GUILLEMONT ; DAVID F.A. LANCOIS ; KOENRAAD J.L.M. ANDRIES ; ISMET DORANGE ; LEO J.J. BACKX ; MAGALI M.S. MOTTE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_PT1898914EE3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; por</language><creationdate>2012</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>LIEVEN MEERPOEL</creatorcontrib><creatorcontrib>ANIL KOUL</creatorcontrib><creatorcontrib>JEROME E.G. GUILLEMONT</creatorcontrib><creatorcontrib>DAVID F.A. LANCOIS</creatorcontrib><creatorcontrib>KOENRAAD J.L.M. ANDRIES</creatorcontrib><creatorcontrib>ISMET DORANGE</creatorcontrib><creatorcontrib>LEO J.J. BACKX</creatorcontrib><creatorcontrib>MAGALI M.S. MOTTE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>LIEVEN MEERPOEL</au><au>ANIL KOUL</au><au>JEROME E.G. GUILLEMONT</au><au>DAVID F.A. LANCOIS</au><au>KOENRAAD J.L.M. ANDRIES</au><au>ISMET DORANGE</au><au>LEO J.J. BACKX</au><au>MAGALI M.S. MOTTE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>QUINOLINE DERIVATIVES AS ANTIBACTERIAL AGENTS</title><date>2012-11-20</date><risdate>2012</risdate><abstract>Use of a compound for the manufacture of a medicament for the treatment of a bacterial infection provided that the bacterial infection is other than a Mycobacterial infection, said compound being a compound of formula (Ia) or (Ib) a pharmaceutically acceptable acid or base addition salt thereof, a stereochemically isomeric form thereof, a tautomeric form thereof or a N-oxide form thereof, wherein R1 is hydrogen, halo, haloalkyl, cyano, hydroxy, Ar, Het, alkyl, alkyloxy, alkylthio, alkyloxyalkyl, alkylthioalkyl, Ar-alkyl or di(Ar)alkyl; p is 1, 2, 3 or 4; R2 is hydrogen, hydroxy, mercapto, alkyloxy, alkyloxyalkyloxy, alkylthio, mono or di(alkyl)amino or a radical of formula; R3 is alkyl, Ar, Ar-alkyl, Het or Het-alkyl; q is 1, 2 or 3; R4 and R5 are hydrogen, alkyl or benzyl; or R4 and R5 together and including the N to which they are attached may form a ring; R6 is hydrogen, halo, haloalkyl, hydroxy, Ar, alkyl, alkyloxy, alkylthio, alkyloxyalkyl, alkythioalkyl, Ar-alkyl or di(Ar)alkyl; or two vicinal R6 radicals may be taken together to form a bivalent radical of formula -CH CH-CH CH-; r is 1, 2, 3, 4 or 5; R7 is hydrogen, alkyl, Ar or Het; R8 is hydrogen or alkyl; R9 is oxo; or R8 and R9 together form the radical -CH CH-N .</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; por
recordid cdi_epo_espacenet_PT1898914EE
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title QUINOLINE DERIVATIVES AS ANTIBACTERIAL AGENTS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T12%3A33%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=LIEVEN%20MEERPOEL&rft.date=2012-11-20&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EPT1898914EE%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true